Press Releases

Filters
November 9, 2022

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial…

Read more
September 13, 2022

Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence

Read more
May 9, 2022

Debiopharm leads investment round for evidence-based digital cancer therapeutic app Mika to empower cancer patients

Read more
March 30, 2022

VivoSense Announces Closing of $25M Series A Financing Round Co-led by Xontogeny and Debiopharm

Read more
January 10, 2022

Debiopharm invests in VeriSIM Life’s $15m series A round to advance AI-enabled drug research

Read more
November 9, 2021

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…

Read more
January 14, 2021

Nucleai and Debiopharm Launch Research Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform

Read more
September 9, 2020

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…

Read more
July 7, 2020

Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform

Read more